•
Dec 31, 2020

Merit Medical Q4 2020 Earnings Report

Merit Medical reported Q4 2020 results, with revenue approximately equal to Q4 2019 and issued FY 2021 guidance.

Key Takeaways

Merit Medical Systems, Inc. reported revenue of $258.0 million for the quarter ended December 31, 2020, essentially flat compared to the prior year period. The company's GAAP EPS was $0.27, compared to a GAAP loss per share of ($0.08) in Q4 2019. Non-GAAP EPS was $0.54, compared to $0.40 in Q4 2019.

Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenue

Q4 2020 core revenue on a constant currency basis down (1.0)% compared to Q4 2019

Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019

Q4 2020 non-GAAP EPS of $0.54, compared to $0.40 in Q4 2019

Total Revenue
$258M
Previous year: $258M
+0.0%
EPS
$0.54
Previous year: $0.4
+35.0%
GAAP Operating Margin
6.2%
Previous year: -1.3%
-576.9%
Non-GAAP Operating Margin
15.7%
Previous year: 12.7%
+23.6%
Gross Profit
$111M
Previous year: $112M
-0.4%
Cash and Equivalents
$56.9M
Previous year: $44.3M
+28.4%
Free Cash Flow
$26M
Previous year: $6.84M
+280.1%
Total Assets
$1.66B
Previous year: $1.76B
-5.3%

Merit Medical

Merit Medical

Merit Medical Revenue by Segment

Forward Guidance

Merit estimates for the year ending December 31, 2021 net revenue in the range of $990 million to $1.01 billion and non-GAAP net income in the range of $104.8 million to $112.7 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income